Objective: Several studies showed that amoxicillin plus clavulanic acid (co-amoxiclav) is one of the most common agents associated to serious Drug Induced Liver Injury (DILI). We estimated the risk of acute serious DILI associated with amoxicillin alone compared with co-amoxiclav, through a multicenter case-control study carried out in nine Italian hospitals from October 2010 to January 2014.
No takes yet. Share an insight, caveat, or question.
Donati et al. (2017) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: